There is high-certainty evidence that HPV vaccines protect against precancerous cervical lesions in young women, particularly those vaccinated aged 15 to 26.[140] HPV vaccines do not increase the risk of serious adverse events.[140] Longer follow-up is needed to monitor the impact of HPV vaccines on cervical cancer.[141]